{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T16:46:22Z","timestamp":1795106782159,"version":"4.10.3"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"NRF","award":["2020R1F1A1076616"],"award-info":[{"award-number":["2020R1F1A1076616"]}]},{"name":"NRF","award":["2021R1I1A3060435"],"award-info":[{"award-number":["2021R1I1A3060435"]}]},{"name":"NRF","award":["2020R1F1A1076616"],"award-info":[{"award-number":["2020R1F1A1076616"]}]},{"DOI":"10.13039\/501100002456","name":"Chonnam National University","doi-asserted-by":"crossref","award":["2022-0036"],"award-info":[{"award-number":["2022-0036"]}],"id":[{"id":"10.13039\/501100002456","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Jeollanam-do Science and Technology R&D Project"},{"name":"Chonnam National University Hospital Biomedical Research Institute","award":["BCRI22051"],"award-info":[{"award-number":["BCRI22051"]}],"id":[{"id":"https:\/\/ror.org\/00f200z37","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurosci"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Histone deacetylase (HDAC) inhibitors affect cell homeostasis, gene expression, and cell cycle progression and promote cell terminal differentiation or apoptosis. However, the effect of HDAC inhibition on SH-SY5Y cells, which are neuroblastoma cells capable of differentiating into neurons under specific conditions, such as in the presence of retinoic acid (RA), is unknown. In this study, we hypothesized that HDAC inhibitors induced the neuronal differentiation of SH-SY5Y cells. To test this hypothesis, we used phase contrast microscopy, immunocytochemistry (ICC), qPCR, and western blotting analysis. MS-275 and valproic acid (VPA), two HDAC inhibitors, were selected to evaluate neuronal differentiation. It was confirmed that cells treated with MS-275 or VPA differentiated into mature neurons, which were distinguished by bipolar or multipolar morphologies with elongated branches. In addition, the mRNA expression of neuronal markers (\n                    <jats:italic>Tuj1<\/jats:italic>\n                    and\n                    <jats:italic>NEFH<\/jats:italic>\n                    ) and the oligodendrocyte marker (\n                    <jats:italic>CNP<\/jats:italic>\n                    ) was significantly increased with MS-275 or VPA treatment compared to that with RA treatment. In addition, the protein expression of the other neuronal markers, Tuj1 and NeuN, was highly increased with HDAC inhibitor treatments compared to that with RA treatment. Furthermore, we confirmed that noncanonical Wnt signaling was upregulated by HDAC inhibitors via MAPK signaling and the Wnt\/JNK pathway. Therefore, both MS-275 and VPA promoted the differentiation of SH-SY5Y cells into mature neurons via the Wnt signaling pathway.\n                  <\/jats:p>","DOI":"10.1186\/s12868-023-00798-0","type":"journal-article","created":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T13:01:51Z","timestamp":1682946111000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Effects of HDAC inhibitors on neuroblastoma SH-SY5Y cell differentiation into mature neurons via the Wnt signaling pathway"],"prefix":"10.1186","volume":"24","author":[{"given":"Jiyun","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinsu","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahesh","family":"Ramalingam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Seong","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujeong","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,1]]},"reference":[{"key":"798_CR1","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.neulet.2018.01.006","volume":"668","author":"S Jang","year":"2018","unstructured":"Jang S, Jeong HS. Histone deacetylase inhibition-mediated neuronal differentiation via the Wnt signaling pathway in human adipose tissue-derived mesenchymal stem cells. Neurosci Lett. 2018;668:24\u201330.","journal-title":"Neurosci Lett"},{"issue":"1","key":"798_CR2","first-page":"1445","volume":"17","author":"Z Liu","year":"2018","unstructured":"Liu Z, et al. HDAC inhibitor LMK235 promotes the odontoblast differentiation of dental pulp cells. Mol Med Rep. 2018;17(1):1445\u201352.","journal-title":"Mol Med Rep"},{"issue":"23","key":"798_CR3","doi-asserted-by":"publisher","first-page":"12702","DOI":"10.3390\/ijms222312702","volume":"22","author":"R Miksiunas","year":"2021","unstructured":"Miksiunas R, et al. Cardiomyogenic differentiation potential of human dilated myocardium-derived mesenchymal stem\/stromal cells: the impact of HDAC inhibitor SAHA and biomimetic matrices. Int J Mol Sci. 2021;22(23):12702.","journal-title":"Int J Mol Sci"},{"key":"798_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2021.101312","volume":"16","author":"G Shanmugam","year":"2022","unstructured":"Shanmugam G, Rakshit S, Sarkar K. HDAC inhibitors: targets for tumor therapy, immune modulation and lung diseases. Transl Oncol. 2022;16: 101312.","journal-title":"Transl Oncol"},{"issue":"28","key":"798_CR5","doi-asserted-by":"publisher","first-page":"12617","DOI":"10.1073\/pnas.1006774107","volume":"107","author":"JE Bradner","year":"2010","unstructured":"Bradner JE, et al. Chemical genetic strategy identifies histone deacetylase 1 (HDAC1) and HDAC2 as therapeutic targets in sickle cell disease. Proc Natl Acad Sci U S A. 2010;107(28):12617\u201322.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"798_CR6","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1038\/s41386-018-0073-1","volume":"43","author":"K Ma","year":"2018","unstructured":"Ma K, et al. Histone deacetylase inhibitor MS-275 restores social and synaptic function in a Shank3-deficient mouse model of autism. Neuropsychopharmacology. 2018;43(8):1779\u201388.","journal-title":"Neuropsychopharmacology"},{"key":"798_CR7","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.neuroscience.2019.08.020","volume":"417","author":"Y Wu","year":"2019","unstructured":"Wu Y, et al. Histone deacetylase inhibitor MS-275 alleviates postoperative cognitive dysfunction in rats by inhibiting hippocampal neuroinflammation. Neuroscience. 2019;417:70\u201380.","journal-title":"Neuroscience"},{"issue":"16","key":"798_CR8","doi-asserted-by":"publisher","first-page":"5771","DOI":"10.3390\/ijms21165771","volume":"21","author":"EC Lee","year":"2020","unstructured":"Lee EC, et al. The histone deacetylase inhibitor (MS-275) promotes differentiation of human dental pulp stem cells into odontoblast-like cells independent of the MAPK signaling system. Int J Mol Sci. 2020;21(16):5771.","journal-title":"Int J Mol Sci"},{"key":"798_CR9","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ejphar.2018.07.057","volume":"835","author":"H Heers","year":"2018","unstructured":"Heers H, et al. Valproic acid as an adjunctive therapeutic agent for the treatment of breast cancer. Eur J Pharmacol. 2018;835:61\u201374.","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"798_CR10","doi-asserted-by":"publisher","first-page":"869","DOI":"10.3892\/or.2021.7937","volume":"45","author":"SA Park","year":"2021","unstructured":"Park SA, et al. Combination treatment with VPA and MSCs-TRAIL could increase anti-tumor effects against intracranial glioma. Oncol Rep. 2021;45(3):869\u201378.","journal-title":"Oncol Rep"},{"key":"798_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.112021","volume":"142","author":"D Singh","year":"2021","unstructured":"Singh D, et al. Hidden pharmacological activities of valproic acid:a new insight. Biomed Pharmacother. 2021;142: 112021.","journal-title":"Biomed Pharmacother"},{"key":"798_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.niox.2019.08.008","volume":"93","author":"T Okubo","year":"2019","unstructured":"Okubo T, et al. Valproic acid promotes mature neuronal differentiation of adipose tissue-derived stem cells through iNOS-NO-sGC signaling pathway. Nitric Oxide. 2019;93:1\u20135.","journal-title":"Nitric Oxide"},{"issue":"4","key":"798_CR13","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.1016\/j.bbrc.2018.08.032","volume":"503","author":"BS Moon","year":"2018","unstructured":"Moon BS, Lu W, Park HJ. Valproic acid promotes the neuronal differentiation of spiral ganglion neural stem cells with robust axonal growth. Biochem Biophys Res Commun. 2018;503(4):2728\u201335.","journal-title":"Biochem Biophys Res Commun"},{"issue":"10","key":"798_CR14","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.it.2018.08.006","volume":"39","author":"WJ Chae","year":"2018","unstructured":"Chae WJ, Bothwell ALM. Canonical and non-canonical Wnt signaling in immune cells. Trends Immunol. 2018;39(10):830\u201347.","journal-title":"Trends Immunol"},{"issue":"1","key":"798_CR15","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41568-020-00307-z","volume":"21","author":"JM Bugter","year":"2021","unstructured":"Bugter JM, Fenderico N, Maurice MM. Mutations and mechanisms of WNT pathway tumour suppressors in cancer. Nat Rev Cancer. 2021;21(1):5\u201321.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"798_CR16","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41401-018-0060-4","volume":"40","author":"WB Fu","year":"2019","unstructured":"Fu WB, Wang WE, Zeng CY. Wnt signaling pathways in myocardial infarction and the therapeutic effects of Wnt pathway inhibitors. Acta Pharmacol Sin. 2019;40(1):9\u201312.","journal-title":"Acta Pharmacol Sin"},{"issue":"5","key":"798_CR17","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.chembiol.2013.03.020","volume":"20","author":"SM Frumm","year":"2013","unstructured":"Frumm SM, et al. Selective HDAC1\/HDAC2 inhibitors induce neuroblastoma differentiation. Chem Biol. 2013;20(5):713\u201325.","journal-title":"Chem Biol"},{"issue":"7","key":"798_CR18","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1007\/s00204-018-2229-5","volume":"92","author":"N Kiweler","year":"2018","unstructured":"Kiweler N, et al. The histone deacetylases HDAC1 and HDAC2 are required for the growth and survival of renal carcinoma cells. Arch Toxicol. 2018;92(7):2227\u201343.","journal-title":"Arch Toxicol"},{"issue":"2","key":"798_CR19","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s00432-019-03118-4","volume":"146","author":"N Kiweler","year":"2020","unstructured":"Kiweler N, et al. Histone deacetylase inhibitors dysregulate DNA repair proteins and antagonize metastasis-associated processes. J Cancer Res Clin Oncol. 2020;146(2):343\u201356.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"18 Pt 1","key":"798_CR20","doi-asserted-by":"publisher","first-page":"6066","DOI":"10.1158\/1078-0432.CCR-04-0537","volume":"10","author":"K Camphausen","year":"2004","unstructured":"Camphausen K, et al. Enhancement of xenograft tumor radiosensitivity by the histone deacetylase inhibitor MS-275 and correlation with histone hyperacetylation. Clin Cancer Res. 2004;10(18 Pt 1):6066\u201371.","journal-title":"Clin Cancer Res"},{"issue":"10","key":"798_CR21","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1242\/bio.20135587","volume":"2","author":"G Franci","year":"2013","unstructured":"Franci G, et al. The class I-specific HDAC inhibitor MS-275 modulates the differentiation potential of mouse embryonic stem cells. Biol Open. 2013;2(10):1070\u20137.","journal-title":"Biol Open"},{"issue":"7","key":"798_CR22","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.1182\/blood-2006-05-021873","volume":"109","author":"I Gojo","year":"2007","unstructured":"Gojo I, et al. Phase 1 and pharmacologic study of MS-275, a histone deacetylase inhibitor, in adults with refractory and relapsed acute leukemias. Blood. 2007;109(7):2781\u201390.","journal-title":"Blood"},{"issue":"24","key":"798_CR23","doi-asserted-by":"publisher","first-page":"6969","DOI":"10.1093\/emboj\/20.24.6969","volume":"20","author":"M Gottlicher","year":"2001","unstructured":"Gottlicher M, et al. Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. EMBO J. 2001;20(24):6969\u201378.","journal-title":"EMBO J"},{"issue":"6","key":"798_CR24","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1111\/j.1365-2184.2009.00633.x","volume":"42","author":"S Lee","year":"2009","unstructured":"Lee S, et al. Histone deacetylase inhibitors decrease proliferation potential and multilineage differentiation capability of human mesenchymal stem cells. Cell Prolif. 2009;42(6):711\u201320.","journal-title":"Cell Prolif"},{"issue":"13","key":"798_CR25","first-page":"3637","volume":"63","author":"RR Rosato","year":"2003","unstructured":"Rosato RR, Almenara JA, Grant S. The histone deacetylase inhibitor MS-275 promotes differentiation or apoptosis in human leukemia cells through a process regulated by generation of reactive oxygen species and induction of p21CIP1\/WAF1 1. Cancer Res. 2003;63(13):3637\u201345.","journal-title":"Cancer Res"},{"issue":"3","key":"798_CR26","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1158\/0008-5472.CAN-03-0799","volume":"64","author":"N Gurvich","year":"2004","unstructured":"Gurvich N, et al. Histone deacetylase is a target of valproic acid-mediated cellular differentiation. Cancer Res. 2004;64(3):1079\u201386.","journal-title":"Cancer Res"},{"issue":"1","key":"798_CR27","doi-asserted-by":"publisher","first-page":"6","DOI":"10.4068\/cmj.2022.58.1.6","volume":"58","author":"S Jang","year":"2022","unstructured":"Jang S, Hwang J, Jeong HS. The role of histone acetylation in mesenchymal stem cell differentiation. Chonnam Med J. 2022;58(1):6\u201312.","journal-title":"Chonnam Med J"},{"key":"798_CR28","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1016\/j.dib.2018.02.058","volume":"17","author":"S Jang","year":"2018","unstructured":"Jang S, Jeong HS. Data for the effect of histone deacetylase inhibitors on voltage- and ligand-gated ion channel gene expression in neurogenic induced-human adipose tissue-derived mesenchymal stem cells. Data Brief. 2018;17:1314\u20139.","journal-title":"Data Brief"},{"key":"798_CR29","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1471-2121-11-25","volume":"11","author":"S Jang","year":"2010","unstructured":"Jang S, et al. Functional neural differentiation of human adipose tissue-derived stem cells using bFGF and forskolin. BMC Cell Biol. 2010;11:25.","journal-title":"BMC Cell Biol"},{"issue":"8","key":"798_CR30","doi-asserted-by":"publisher","first-page":"4051","DOI":"10.1007\/s12035-021-02372-3","volume":"58","author":"B Mages","year":"2021","unstructured":"Mages B, et al. The cytoskeletal elements MAP2 and NF-L show substantial alterations in different stroke models while elevated serum levels highlight especially MAP2 as a sensitive biomarker in stroke patients. Mol Neurobiol. 2021;58(8):4051\u201369.","journal-title":"Mol Neurobiol"},{"issue":"2","key":"798_CR31","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200078","volume":"10","author":"FC Loonstra","year":"2023","unstructured":"Loonstra FC, et al. Neuroaxonal and glial markers in patients of the same age with multiple sclerosis. Neurol Neuroimmunol Neuroinflamm. 2023;10(2): e200078.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"1","key":"798_CR32","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1136\/jnnp-2021-327186","volume":"93","author":"M Pipis","year":"2022","unstructured":"Pipis M, et al. Charcot-Marie-Tooth disease type 2CC due to NEFH variants causes a progressive, non-length-dependent, motor-predominant phenotype. J Neurol Neurosurg Psychiatry. 2022;93(1):48\u201356.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"7803","key":"798_CR33","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41586-020-2188-x","volume":"580","author":"K Luck","year":"2020","unstructured":"Luck K, et al. A reference map of the human binary protein interactome. Nature. 2020;580(7803):402\u20138.","journal-title":"Nature"},{"issue":"7","key":"798_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108050","volume":"32","author":"C Haenig","year":"2020","unstructured":"Haenig C, et al. Interactome mapping provides a network of neurodegenerative disease proteins and uncovers widespread protein aggregation in affected brains. Cell Rep. 2020;32(7): 108050.","journal-title":"Cell Rep"},{"issue":"8","key":"798_CR35","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1016\/S0968-0896(01)00103-1","volume":"9","author":"DV Crabtree","year":"2001","unstructured":"Crabtree DV, et al. Tubulins in the primate retina: evidence that xanthophylls may be endogenous ligands for the paclitaxel-binding site. Bioorg Med Chem. 2001;9(8):1967\u201376.","journal-title":"Bioorg Med Chem"},{"issue":"7","key":"798_CR36","doi-asserted-by":"publisher","first-page":"3574","DOI":"10.3390\/ijms23073574","volume":"23","author":"I Baptista","year":"2022","unstructured":"Baptista I, et al. TKTL1 knockdown impairs hypoxia-induced glucose-6-phosphate dehydrogenase and glyceraldehyde-3-phosphate dehydrogenase overexpression. Int J Mol Sci. 2022;23(7):3574.","journal-title":"Int J Mol Sci"},{"key":"798_CR37","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.brainres.2009.12.012","volume":"1313","author":"S Jang","year":"2010","unstructured":"Jang S, et al. Neuroprotective effects of (-)-epigallocatechin-3-gallate against quinolinic acid-induced excitotoxicity via PI3K pathway and NO inhibition. Brain Res. 2010;1313:25\u201333.","journal-title":"Brain Res"},{"key":"798_CR38","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/178618","volume":"2015","author":"S Jang","year":"2015","unstructured":"Jang S, Park JS, Jeong HS. Neural differentiation of human adipose tissue-derived stem cells involves activation of the Wnt5a\/JNK signalling. Stem Cells Int. 2015;2015: 178618.","journal-title":"Stem Cells Int"},{"issue":"3","key":"798_CR39","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1002\/jcb.20544","volume":"96","author":"HH Cho","year":"2005","unstructured":"Cho HH, et al. Induction of osteogenic differentiation of human mesenchymal stem cells by histone deacetylase inhibitors. J Cell Biochem. 2005;96(3):533\u201342.","journal-title":"J Cell Biochem"},{"issue":"5","key":"798_CR40","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1021\/acs.jproteome.9b00752","volume":"19","author":"K Brenig","year":"2020","unstructured":"Brenig K, et al. The proteomic landscape of cysteine oxidation that underpins retinoic acid-induced neuronal differentiation. J Proteome Res. 2020;19(5):1923\u201340.","journal-title":"J Proteome Res"},{"key":"798_CR41","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.neulet.2018.10.002","volume":"690","author":"H Zhao","year":"2019","unstructured":"Zhao H, et al. Combined use of bFGF\/EGF and all-trans-retinoic acid cooperatively promotes neuronal differentiation and neurite outgrowth in neural stem cells. Neurosci Lett. 2019;690:61\u20138.","journal-title":"Neurosci Lett"},{"key":"798_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2020.105772","volume":"205","author":"H Yang","year":"2021","unstructured":"Yang H, et al. Folic acid promotes proliferation and differentiation of porcine pancreatic stem cells into insulin-secreting cells through canonical Wnt and ERK signaling pathway. J Steroid Biochem Mol Biol. 2021;205: 105772.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"11","key":"798_CR43","doi-asserted-by":"publisher","first-page":"8293","DOI":"10.1002\/jcp.29674","volume":"235","author":"RPF Abuna","year":"2020","unstructured":"Abuna RPF, et al. Frizzled 6 disruption suppresses osteoblast differentiation induced by nanotopography through the canonical Wnt signaling pathway. J Cell Physiol. 2020;235(11):8293\u2013303.","journal-title":"J Cell Physiol"},{"issue":"4","key":"798_CR44","doi-asserted-by":"publisher","first-page":"634","DOI":"10.3390\/cancers13040634","volume":"13","author":"R Jenke","year":"2021","unstructured":"Jenke R, et al. Anticancer therapy with HDAC inhibitors: mechanism-based combination strategies and future perspectives. Cancers. 2021;13(4):634.","journal-title":"Cancers"},{"key":"798_CR45","first-page":"537","volume":"11","author":"S Shukla","year":"2020","unstructured":"Shukla S, Tekwani BL. Histone deacetylases inhibitors in neurodegenerative diseases. Neuroprotect Neuronal Different Front Pharmacol. 2020;11:537.","journal-title":"Neuroprotect Neuronal Different Front Pharmacol"},{"issue":"21","key":"798_CR46","doi-asserted-by":"publisher","first-page":"12460","DOI":"10.1021\/acs.jmedchem.0c00830","volume":"63","author":"TCS Ho","year":"2020","unstructured":"Ho TCS, Chan AHY, Ganesan A. Thirty years of HDAC inhibitors: 2020 insight and hindsight. J Med Chem. 2020;63(21):12460\u201384.","journal-title":"J Med Chem"},{"issue":"2","key":"798_CR47","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/s41419-023-05611-8","volume":"14","author":"X Liu","year":"2023","unstructured":"Liu X, et al. Differential regulation of H3K9\/H3K14 acetylation by small molecules drives neuron-fate-induction of glioma cell. Cell Death Dis. 2023;14(2):142.","journal-title":"Cell Death Dis"},{"key":"798_CR48","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.ijbiomac.2022.05.021","volume":"210","author":"AHA Kelkawi","year":"2022","unstructured":"Kelkawi AHA, et al. Differentiation of PC12 cell line into neuron by Valproic acid encapsulated in the stabilized core-shell liposome-chitosan nano carriers. Int J Biol Macromol. 2022;210:252\u201360.","journal-title":"Int J Biol Macromol"},{"key":"798_CR49","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.bbrc.2021.12.005","volume":"589","author":"A Satoh","year":"2022","unstructured":"Satoh A, et al. Valproic acid promotes differentiation of adipose tissue-derived stem cells to neuronal cells selectively expressing functional N-type voltage-gated Ca(2+) channels. Biochem Biophys Res Commun. 2022;589:55\u201362.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"798_CR50","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13072-021-00432-5","volume":"14","author":"C Baumann","year":"2021","unstructured":"Baumann C, et al. Changes in chromatin accessibility landscape and histone H3 core acetylation during valproic acid-induced differentiation of embryonic stem cells. Epigenet Chromatin. 2021;14(1):58.","journal-title":"Epigenet Chromatin"},{"issue":"3","key":"798_CR51","doi-asserted-by":"publisher","first-page":"534","DOI":"10.3390\/cells11030534","volume":"11","author":"Y Yu","year":"2022","unstructured":"Yu Y, et al. Valproic acid-induced CCN1 promotes osteogenic differentiation by increasing CCN1 protein stability through HDAC1 inhibition in tonsil-derived mesenchymal stem cells. Cells. 2022;11(3):534.","journal-title":"Cells"},{"key":"798_CR52","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/1471-2121-9-66","volume":"9","author":"GA Jung","year":"2008","unstructured":"Jung GA, et al. Valproic acid induces differentiation and inhibition of proliferation in neural progenitor cells via the beta-catenin-Ras-ERK-p21Cip\/WAF1 pathway. BMC Cell Biol. 2008;9:66.","journal-title":"BMC Cell Biol"},{"issue":"1","key":"798_CR53","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/gb-2004-6-1-204","volume":"6","author":"L Dehmelt","year":"2005","unstructured":"Dehmelt L, Halpain S. The MAP2\/Tau family of microtubule-associated proteins. Genome Biol. 2005;6(1):204.","journal-title":"Genome Biol"},{"issue":"10","key":"798_CR54","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1002\/acn3.50890","volume":"6","author":"M De Schaepdryver","year":"2019","unstructured":"De Schaepdryver M, et al. Serum neurofilament heavy chains as early marker of motor neuron degeneration. Ann Clin Transl Neurol. 2019;6(10):1971\u20139.","journal-title":"Ann Clin Transl Neurol"},{"key":"798_CR55","doi-asserted-by":"publisher","first-page":"6658271","DOI":"10.1155\/2021\/6658271","volume":"2021","author":"M Ramalingam","year":"2021","unstructured":"Ramalingam M, Jang S, Jeong HS. Therapeutic effects of conditioned medium of neural differentiated human bone marrow-derived stem cells on rotenone-induced alpha-synuclein aggregation and apoptosis. Stem Cells Int. 2021;2021:6658271.","journal-title":"Stem Cells Int"},{"issue":"6","key":"798_CR56","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1016\/j.ejmech.2010.02.030","volume":"45","author":"P Bertrand","year":"2010","unstructured":"Bertrand P. Inside HDAC with HDAC inhibitors. Eur J Med Chem. 2010;45(6):2095\u2013116.","journal-title":"Eur J Med Chem"},{"key":"798_CR57","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.576391","volume":"8","author":"IC Chen","year":"2020","unstructured":"Chen IC, Sethy B, Liou JP. Recent update of HDAC inhibitors in lymphoma. Front Cell Dev Biol. 2020;8: 576391.","journal-title":"Front Cell Dev Biol"},{"issue":"23","key":"798_CR58","doi-asserted-by":"publisher","first-page":"10333","DOI":"10.1523\/JNEUROSCI.22-23-10333.2002","volume":"22","author":"M Marin-Husstege","year":"2002","unstructured":"Marin-Husstege M, et al. Histone deacetylase activity is necessary for oligodendrocyte lineage progression. J Neurosci. 2002;22(23):10333\u201345.","journal-title":"J Neurosci"},{"issue":"2","key":"798_CR59","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.devcel.2018.08.014","volume":"47","author":"SC Ti","year":"2018","unstructured":"Ti SC, Alushin GM, Kapoor TM. Human beta-tubulin isotypes can regulate microtubule protofilament number and stability. Dev Cell. 2018;47(2):175\u201390.","journal-title":"Dev Cell"},{"issue":"11","key":"798_CR60","doi-asserted-by":"publisher","first-page":"6120","DOI":"10.1073\/pnas.97.11.6120","volume":"97","author":"C Daly","year":"2000","unstructured":"Daly C, et al. Synaptophysin regulates clathrin-independent endocytosis of synaptic vesicles. Proc Natl Acad Sci U S A. 2000;97(11):6120\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"798_CR61","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1186\/s13287-021-02621-1","volume":"12","author":"X Wang","year":"2021","unstructured":"Wang X, et al. Valproic acid promotes the in vitro differentiation of human pluripotent stem cells into spermatogonial stem cell-like cells. Stem Cell Res Ther. 2021;12(1):553.","journal-title":"Stem Cell Res Ther"},{"issue":"14","key":"798_CR62","doi-asserted-by":"publisher","first-page":"5397","DOI":"10.1073\/pnas.0507237103","volume":"103","author":"MP Creyghton","year":"2006","unstructured":"Creyghton MP, et al. PR130 is a modulator of the Wnt-signaling cascade that counters repression of the antagonist Naked cuticle. Proc Natl Acad Sci U S A. 2006;103(14):5397\u2013402.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"798_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2020.188453","volume":"1874","author":"M Dzulko","year":"2020","unstructured":"Dzulko M, et al. The PP2A subunit PR130 is a key regulator of cell development and oncogenic transformation. Biochim Biophys Acta Rev Cancer. 2020;1874(2): 188453.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"1","key":"798_CR64","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/s41467-018-03096-0","volume":"9","author":"A Goder","year":"2018","unstructured":"Goder A, et al. HDAC1 and HDAC2 integrate checkpoint kinase phosphorylation and cell fate through the phosphatase-2A subunit PR130. Nat Commun. 2018;9(1):764.","journal-title":"Nat Commun"},{"key":"798_CR65","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3389\/fnagi.2019.00062","volume":"11","author":"Q Zeng","year":"2019","unstructured":"Zeng Q, et al. Valproic acid stimulates hippocampal neurogenesis via activating the Wnt\/beta-catenin signaling pathway in the APP\/PS1\/Nestin-GFP triple transgenic mouse model of Alzheimer\u2019s disease. Front Aging Neurosci. 2019;11:62.","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"798_CR66","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12929-022-00785-3","volume":"29","author":"A Gyawali","year":"2022","unstructured":"Gyawali A, et al. Monocarboxylate transporter functions and neuroprotective effects of valproic acid in experimental models of amyotrophic lateral sclerosis. J Biomed Sci. 2022;29(1):2.","journal-title":"J Biomed Sci"},{"issue":"4","key":"798_CR67","doi-asserted-by":"publisher","first-page":"504","DOI":"10.5607\/en.2019.28.4.504","volume":"28","author":"T Kim","year":"2019","unstructured":"Kim T, et al. HDAC inhibition by valproic acid induces neuroprotection and improvement of PD-like behaviors in LRRK2 R1441G transgenic mice. Exp Neurobiol. 2019;28(4):504\u201315.","journal-title":"Exp Neurobiol"},{"issue":"9","key":"798_CR68","first-page":"1289","volume":"54","author":"S Liu","year":"2022","unstructured":"Liu S, et al. Combined cell grafting and VPA administration facilitates neural repair through axonal regeneration and synaptogenesis in traumatic brain injury. Acta Biochim Biophys Sin. 2022;54(9):1289\u2013300.","journal-title":"Acta Biochim Biophys Sin"},{"key":"798_CR69","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.biopha.2018.11.082","volume":"110","author":"X Cheng","year":"2019","unstructured":"Cheng X, et al. Therapeutic potential of targeting the Wnt\/beta-catenin signaling pathway in colorectal cancer. Biomed Pharmacother. 2019;110:473\u201381.","journal-title":"Biomed Pharmacother"},{"key":"798_CR70","doi-asserted-by":"publisher","first-page":"170","DOI":"10.3389\/fcell.2018.00170","volume":"6","author":"KS Houschyar","year":"2018","unstructured":"Houschyar KS, et al. Wnt pathway in bone repair and regeneration\u2014what do we know so far. Front Cell Dev Biol. 2018;6:170.","journal-title":"Front Cell Dev Biol"}],"container-title":["BMC Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12868-023-00798-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12868-023-00798-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12868-023-00798-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T14:02:54Z","timestamp":1682949774000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurosci.biomedcentral.com\/articles\/10.1186\/s12868-023-00798-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,1]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["798"],"URL":"https:\/\/doi.org\/10.1186\/s12868-023-00798-0","relation":{},"ISSN":["1471-2202"],"issn-type":[{"value":"1471-2202","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,1]]},"assertion":[{"value":"28 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors claim that there are no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"28"}}